Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Prev… read more
-
ETF
Equity
- years
45 holdings
$32.15
Price-0.36%
-$0.12
$49.403m
Small
$27.924k
Avg Volume$81.704m
$33.05
NAV0.75%
Expense Ratio1.46%
Yield$0.47
Dividend